Is anastrozole overused on TRT? Here's what the data says

What did @awakinmenshealth actually say?

The creator argues that anastrozole is overprescribed on TRT, and that two specific practices are wrong: starting it immediately when TRT begins, and prescribing it purely because estradiol falls outside the standard lab reference range. Their core point is that estrogen is necessary for cognition, bone density, muscle, and tissue health, so suppressing it carelessly causes harm.

To be fair, they never tell you to never use anastrozole. They explicitly say opinions range from "absolutely never" to fully pro-use, and they're staking out a middle position. The transcript also flags that standard estradiol reference ranges don't reflect men on TRT. That is a genuinely important nuance that a lot of online TRT content skips entirely.

Does the science back this up?

Mostly, yes. The evidence that estrogen matters for male health is not fringe opinion. It is well-established. What is less clear is exactly where the threshold for harm sits in men on exogenous testosterone.

Finkelstein et al. (2013, New England Journal of Medicine) showed that estradiol deficiency in men causes fat accumulation and reduced libido, independent of testosterone. That study was landmark because it isolated estrogen's role using an aromatase inhibitor plus testosterone, precisely the intervention this creator is warning against using casually. Khera et al. have published multiple times on how aggressive estrogen suppression in TRT patients produces worse symptomatic outcomes, not better ones. The Endocrine Society's 2018 clinical practice guidelines for male hypogonadism do not recommend routine anastrozole use and explicitly caution against it in the absence of symptoms.

The point about standard lab ranges is also supported. Most reference intervals for estradiol were derived from populations not on exogenous testosterone, so applying them to TRT patients without adjustment is methodologically weak.

What did they get wrong (or right)?

They got the broad strokes right. Reflexive anastrozole prescribing based solely on a number outside a population-derived reference range is a real problem in some TRT clinics, and the science does not support that practice.

Where the video is vague, though, is on what should actually trigger anastrozole use. Saying you "should not" take it because labs are elevated is reasonable advice. But the creator stops short of telling you when it is appropriate. Men with gynecomastia, significant symptomatic estrogen excess, or specific cardiovascular risk profiles may genuinely benefit from it. Helo et al. (2015, Journal of Sexual Medicine) found anastrozole improved sperm parameters in hypogonadal men, which is a legitimate clinical use. The creator's framing implies anastrozole is mostly a problem drug, but that oversimplifies.

The phrase "what are we doing to that tissue" suggests potential harm from suppression, which is directionally correct, but the video offers no specifics. That is not misinformation, but it is incomplete enough to leave viewers without actionable guidance.

What should you actually know?

Estradiol is not your enemy on TRT. Neither is anastrozole, used correctly. The actual clinical question is whether your symptoms match your labs, not whether a number crossed a line on a reference sheet built for a different population.

Symptom-driven prescribing is what the evidence supports. Men on TRT who have elevated estradiol but no symptoms like gynecomastia, water retention, or mood changes do not automatically need an aromatase inhibitor. Conversely, men with a clear clinical picture of estrogen excess who are symptomatic may benefit from one, even if some practitioners are too quick to reach for it.

If you are on TRT and your provider is adding anastrozole at your first follow-up without asking about symptoms, that is worth questioning. A good provider will run a full panel, ask how you feel, and make individualized decisions. Labs are a tool, not a diagnosis. The creator is right to push back on algorithmic prescribing. They are less helpful on what good prescribing actually looks like.